Jubilant Ingrevia has raised Rs 48 crore through Commercial Papers (‘CPs’) on December 27, 2024. Maturity of the said Commercial Papers will be on February 25, 2025. Tenure of the instrument is 60 days.
The Finance Committee, at its meeting held on October 23, 2024 approved issuance of Commercial Papers up to an amount of Rs 600 crore outstanding at any point of time, in one or more tranches. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 148 crore.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
